OBJECTIVE Misuse of prescription stimulant medication is a prevalent problem on American college campuses; however, few studies have been conducted beyond the United States. Although Iceland has the highest methylphenidate prescription rates in the world, prevalence of stimulant misuse within the Icelandic college student population remains to be investigated. METHOD We examined the prevalenc...

New research has implicated a potential target in the treatment of stimulant abuse. As with opioid abuse, stimulant abuse consists of a primary group for substance abuse disorders. However, there is no medication for the treatment of stimulant abuse such as amphetamines, substrates for the dopamine transporter, and cocaine, a dopamine reuptake inhibitor. Stimulants have in common a capacity to ...

Pharmacotherapy for the treatment of attention-deficit/ hyperactivity disorder (ADHD) originally consisted primarily of stimulant medications in immediate-release preparations dosed multiple times per day. Data demonstrating the efficacy of these stimulant medications for the treatment of ADHD and their role in treating children was well established by the 1970s. Multiple formulations of the st...

BACKGROUND Childhood attention-deficit/hyperactivity disorder (ADHD) has been associated with childhood and adult obesity, and stimulant use with delayed childhood growth, but the independent influences are unclear. No longitudinal studies have examined associations of ADHD diagnosis and stimulant use on BMI trajectories throughout childhood and adolescence. METHODS We used longitudinal elect...

BACKGROUND Few studies have examined the impact of stimulant use on outcome in early psychosis. Ceasing substance use may lead to positive outcomes in psychosis. AIMS To examine whether baseline cannabis or stimulant disorders and ongoing drug use predict readmission within 2 years of a first psychosis admission. METHOD Predictors of readmission were examined with Cox regression in 7269 peo...

Objective: Stimulant medication is an efficacious and first-line approach to treating ADHD in adolescence. However, less is known about the effectiveness of this approach as a treatment in real-world settings. The complicated nature of the secondary school environment and documented adolescent nonadherence with stimulant medication may undermine the exportability of this approach. Method: This ...

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA GERVAIS DE LIYIS B, TJANDRA D, MARESKA V, SUTEDJA J, PURNAMASIDHI C, KRISNAWARDANI K. C. Poly(Ethylene Glycol)-Poly(Lactic Acid) TLR7 Agonist as a Novel HBsAg Immune Response Stimulant. Family Medicine & Primary Care Review. 2023;25(1):87-92. doi:10.5114/fmpcr.2023.125499. APA LIYIS, B., TJANDRA, D., MARESKA, V., ...